Similar articles

Abstract: The correlation of serum arylesterase (PON1) activity on phenylacetate determined by an integrated method to classical biochemical indexes of liver damage was investigated for the use of PON1 activity to evaluate liver damage. PON1 reaction curve as absorbance at 270 nm for 0.20 mmol/L phenylacetate hydrolysis was analyzed by the integrated method to determine maximal PON1 reaction rate. Classical biochemical indexes of liver damage were determined routinely. The 95% confidence threshold of PON1 activity in sera from healthy individuals was 2.12 mkat/L [(4.73±1.31) mkat/L, n=105]. PON1 activity in clinical sera was closely correlated to serum albumin, total protein and the ratio of albumin to globulins, but was weakly correlated to both direct and total bilirubin in serum. There were no correlations of PON1 activity to γ-glutamyltransferase, alkaline phosphatase, alanine aminotransferase and aspartate aminotransferase. Among 127 clinical sera with PON1 activity>2.12 mkat/L, there were 92% healthy individuals examined by albumin, 90% healthy individuals examined by total protein, 88% healthy individuals examined by total bilirubin, 86% healthy individuals examined by direct bilirubin and 64% healthy individuals examined by the ratio of albumin to globulins, respectively. In each group of healthy individuals judged by classical biochemical indexes of close correlation to PON1 activity, percentage of healthy individuals examined by PON1 activity was always >80%. These results suggested PON1 activity on phenylacetate estimated by the integrated method was also suitable for the evaluation of liver damage.

[1] Berkowitz, G.S., Wetmur, J.G., Birman-Deych, E., Obel, J., Lapinski, R.H., Godbold, J.H., Holzman, I.R., Wolff, M.S., 2004. In utero pesticide exposure, maternal paraoxonase activity, and head circumference. Environ. Health Perspect, 112(3):388-391.

[2] Charlton-Menys, V., Liu, Y., Durrington, P.N., 2006. Semiautomated method for the determination of serum paraoxonase activity using paraoxon as substrate. Clin. Chem., 52(3):453-457.

[3] Ferre, N., Camps, J., Prats, E., Villela, E., Paul, A., Figuera, L., Joven, J., 2002. Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage. Clin. Chem., 48(2):261-268.

[4] Harel, M., Aharoni, A., Gaidukov, L., Brumshtein, B., Khersonsky, O., Meged, R., Dvir, H., Ravelli, R.B., McCarthy, A., Toker, L., et al., 2004. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat. Struct. Mol. Biol., 11(5):412-419.

[5] James, R.W., 2006. A long and winding road: defining the biological role and clinical importance of paraoxonases. Clin. Chem. Lab. Med., 44(9):1052-1059.

[6] Junge, W., Klees, H., 1984. 1,2-Arylesterase. Methods Enzym. Anal., 4:8-14.

[7] Liao, F., 2002. The Software for Kinetic Analysis of Enzyme Reaction Process. Chongqing Copyright Bureau, China, 31-2002-software-875.

[8] Liao, F., Liu, W.L., Zhou, Q.X., Zeng, Z.C., Zuo, Y.P., 2001. Assay of serum arylesterase activity by fitting reaction curve to an integrated rate equation. Clin. Chim. Acta, 314(1/2):67-76.

[9] Liao, F., Tian, K.C., Yang, X., Zhou, Q.X., Zeng, Z.C., Zuo, Y.P., 2003a. Kinetic substrate quantification by fitting the enzyme reaction curve to the integrated Michaelis-Menten equation. Anal. Bioanal. Chem., 375(6):756-762.

[10] Liao, F., Li, J.C., Zeng, Z.C., Zuo, Y.P., 2003b. Measurement of mouse liver glutathione S-transferase activity by the integrated method. J. Med. Coll. PLA, 18(5):295-300.

[11] Liao, F., Wang, J.H., Zeng, Z.C., Kang, G.F., Zuo, Y.P., Wang, Y.M., Wang, N., Yuan, X.M., Song, Z., Yu, T.T., Yang, L., 2004a. Measurement of serum arylesterase activity by the integrated method. J. Third Mill. Med. Univ., 26(10):923-925 (in Chinese).

[12] Liao, F., Zhu, X.Y., Wang, Y.M., Zeng, Z.C., Zuo, Y.P., 2004b. Assay of uricase activity by the integrated method at substrate concentration higher than Michaelis-Menten constant. J. Fourth Mill. Med. Univ., 25(17):1551-1554 (in Chinese).

[13] Liao, F., Zhu, X.Y., Wang, Y.M., Zuo, Y.P., 2005a. The comparison of the estimation of enzyme kinetic parameters by fitting reaction curve to the integrated Michaelis-Menten rate equations of different predictor variables. J. Biochem. Biophys. Methods, 62(1):13-24.

[14] Liao, F., Zhao, Y.S., Zhao, L.N., Tao, J., Zhu, X.Y., Wang, Y.M., Zuo, Y.P., 2005b. Kinetic method for enzymatic analysis by predicting background with uricase reaction as model. J. Med. Coll. PLA, 20(6):338-344.

[15] Liao, F., Zhao, Y.S., Zhao, L.N., Tao, J., Zhu, X.Y., Liu, L., 2006. The evaluation of a direct kinetic method for serum uric acid assay by predicting the background absorbance of uricase reaction solution with an integrated method. J. Zhejiang Univ. Sci. B, 7(6):497-502.

[16] Liao, F., Zhao, L.N., Zhao, Y.S., Tao, J., Zuo, Y.P., 2007. Integrated rate equation considering product inhibition and its application to kinetic assay of serum ethanol. Anal. Sci., in press.

[17] Mackness, M.I., Durrington, P.N., Mackness, B., 2004. The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention. Am. J. Cardiovasc. Drugs, 4(4):211-217.

[18] Nakanishi, M., Takanami, Y., Maruyama, T., Murata, M., Motohashi, Y., Nakano, S., Uchida, K., Maruyama, C., Kyotani, S., Tsushima, M., 2003. The ratio of serum paraoxonase/arylesterase activity using an improved assay for arylesterase activity to discriminate PON1_R192 from PON1_Q192. J. Atheroscler Thromb., 10(6):337-342.

[19] Zhao, Y.S., Zhao, L.N., Yang, G.Q., Tao, J., Bu, Y.Q., Liao, F., 2006a. Characterization of an intracellular uricase from Bacillus fastidious ATCC 26904 and its application to serum uric acid assay by a patented kinetic method. Biotechnol. Appl. Biochem., 45(2):75-80.

[20] Zhao, L.N., Tao, J., Zhao, Y.S., Liao, F., 2006b. Quantification of reduced glutathione by analyzing glutathione-S-transferase reaction process taking into account of product inhibition. J. Xi’an Jiaotong Univ. Med. Sci., 27(3):300-303 (in Chinese).